Evidence map›Paper›PMID 22414897›Full record

ReviewNature reviews. Molecular cell biology2012

Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Anna C Calkin, Peter Tontonoz

Abstract readReview
In one paragraph

Review in Nature reviews. Molecular cell biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 392 papers.

0numbers the graph read from it
0cells of the map it votes in
392citing papers in PubMed
59.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

392 citing papers in PubMed, 778 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

332 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Anna C CalkinHoward Hughes Medical Institute, Department of Pathology and Laboratory Medicine, University of California, 675 Charles E Young Drive South, Los Angeles, California 90095, USA. acalkin@mednet.ucla.edu
Peter Tontonoz
Howard Hughes Medical Institute · USUniversity of California, Los Angeles · US

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
NUCLEAR RECEPTOR SIGNALING PATHWAYS IN ATHEROGENESISR01HL066088 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TONTONOZ, PETER J · 2001 to 2018
$5.4M
Howard Hughes Medical InstituteNHLBI NIH HHS HL030568NHLBI NIH HHS HL066088NHLBI NIH HHS P01 HL030568NHLBI NIH HHS R01 HL066088
6 · The paper itself

Abstract

Nuclear receptors are integrators of hormonal and nutritional signals, mediating changes to metabolic pathways within the body. Given that modulation of lipid and glucose metabolism has been linked to diseases including type 2 diabetes, obesity and atherosclerosis, a greater understanding of pathways that regulate metabolism in physiology and disease is crucial. The liver X receptors (LXRs) and the farnesoid X receptors (FXRs) are activated by oxysterols and bile acids, respectively. Mounting evidence indicates that these nuclear receptors have essential roles, not only in the regulation of cholesterol and bile acid metabolism but also in the integration of sterol, fatty acid and glucose metabolism.

Indexed as

AnimalsAtherosclerosisBile Acids and SaltsCholesterolDiabetes Mellitus, Type 2Gene Expression RegulationGlucoseHumansLipid MetabolismLiver X ReceptorsObesityOrphan Nuclear ReceptorsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearRNA-Binding ProteinsSterolsBile Acids and SaltsCholesterolFxr1h protein, mouseGlucoseLiver X ReceptorsOrphan Nuclear ReceptorsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearRNA-Binding ProteinsSterols

Identifiers

PMID22414897
PMCPMC3597092
OpenAlexW2005911243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.